Reckitt Benckiser Group plc (RB) has announced that they are recalling specific batches of Durex condoms after they did not pass their required safety standards. This means there is a risk that the condom might tear or leak reducing its protection from sexually-transmitted diseases and pregnancy. People are advised to check if they have any [...]
4,000 strokes were prevented in England between 2015 and 2016 due to the increased use of anticoagulant drugs among patients with a common heart rhythm disorder, according to new analysis part-funded by British Heart Foundation (BHF) and published in the European Heart Journal. Atrial fibrillation (AF) has been diagnosed in around 1.3 million people in [...]
The US Food and Drug Administration recently approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents aged 12 and older with rare tumours of the adrenal gland (pheochromocytoma or paraganglioma) that can’t be surgically removed (unresectable), have spread beyond the original tumour site, and require systemic anticancer therapy. [...]
Something as seemingly harmless as a heartburn pill could lead cancer patients to take a turn for the worse. A University of Alberta (U of A) study, published in journal, JAMA Oncology, discovered that proton pump inhibitors (PPIs), which are very common medications for heartburn and gastrointestinal bleeding, decrease effects of capecitabine, a type of [...]
Pharmacists are being urged to be aware of patients coming to them with potential signs and symptoms of mouth cancer after it emerged that the public are very likely to turn to them, rather than their dentist or doctor, if they have symptoms related to mouth cancer. New research shows that one in 10 people [...]
Research presented at this year’s European Respiratory Society (ERS) International Congress in London shows that exposure to antibiotics early in life is related to increased risk of developing allergies later in life. The research is by Dr Fariba Ahmadizar, Utrecht University, Netherlands and colleagues. Some previous research has suggested that early life exposure to antibiotics [...]
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, has announced results from the EGALITY trial in which the primary endpoint of achieving equivalence in Psoriasis Area and Severity Index (PASI) 75 response rates at week 12 was met. The study – reported on www.news-medical.net – compared the safety and efficacy of [...]
The 21 candidates who are standing in the three national pharmacy board elections have just been announced. In the 2016 National Pharmacy Board elections, there are five non-sectoral vacancies on the English Pharmacy Board, three non-sectoral places on the Scottish Pharmacy Board, and two community places, one vacancy for any eligible member, and one casual [...]
